UnicoCell Biomed Co (TPE:6794) Common Stock: NT$636.37 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6794 UnicoCell Biomed Co Ltd TPE:6794
83 GF Score
Price NT$78.30
GF Value NT$101.84
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is UnicoCell Biomed Co Common Stock?

UnicoCell Biomed Co TPE:6794 -1.01% 83 Common Stock is NT$636.37 Mil as of Dec. 2025. GuruFocus rates TPE:6794 with a GF Score™ of 83/100 and a GF Value™ of NT$101.84 (Modestly Undervalued). The stock has 4 warning signs investors should review.

UnicoCell Biomed Co's quarterly common stock stayed the same from Jun. 2025 (NT$606.79 Mil) to Sep. 2025 (NT$606.79 Mil) but then increased from Sep. 2025 (NT$606.79 Mil) to Dec. 2025 (NT$636.37 Mil).

UnicoCell Biomed Co's annual common stock increased from Dec. 2023 (NT$556.85 Mil) to Dec. 2024 (NT$584.11 Mil) and increased from Dec. 2024 (NT$584.11 Mil) to Dec. 2025 (NT$636.37 Mil).

UnicoCell Biomed Co Common Stock Historical Data

* Premium members only.

The historical data trend for UnicoCell Biomed Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnicoCell Biomed Co Common Stock Chart

UnicoCell Biomed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only 377.75 423.61 556.85 584.11 636.37

UnicoCell Biomed Co Quarterly Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 584.11 606.11 606.79 606.79 636.37
TPE:6794
83GF Score
UnicoCell Biomed Co Ltd TPE:6794
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnicoCell Biomed Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$636.37 Mil mean?
UnicoCell Biomed Co (TPE:6794) has a Common Stock of NT$636.37 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on UnicoCell Biomed Co and its competitors.
Is UnicoCell Biomed Co's Common Stock too high?
UnicoCell Biomed Co's current Common Stock is NT$636.37 Mil. Overall, UnicoCell Biomed Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnicoCell Biomed Co's Common Stock compare to VRTX and REGN?
UnicoCell Biomed Co's Common Stock of NT$636.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on UnicoCell Biomed Co and its competitors. UnicoCell Biomed Co's current Common Stock is NT$636.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnicoCell Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, UnicoCell Biomed Co (TPE:6794) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$101.84, compared to a current price of NT$78.30 — trading 23.1% below its estimated fair value. The current Common Stock is NT$636.37 Mil. UnicoCell Biomed Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For UnicoCell Biomed Co (TPE:6794), the current Common Stock is NT$636.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnicoCell Biomed Co (TPE:6794) Overvalued in 2026?

Based on GuruFocus' analysis, UnicoCell Biomed Co stock appears to be undervalued. The current stock price of NT$78.30 is trading 23.1% below its estimated GF Value™ of NT$101.84. GuruFocus considers UnicoCell Biomed Co to be Modestly Undervalued.

Key valuation signals for TPE:6794:

  • Common Stock: NT$636.37 Mil
  • GF Value™: NT$101.84 vs. price of NT$78.30 (23.1% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the TPE:6794 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnicoCell Biomed Co Business Description

Address Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494
UnicoCell Biomed Co Ltd is engaged in new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D. It focuses on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life. The company's products include Allogeneic Adipose Stem Cell Bank, Autologous Stem Cell Therapy, Conditioned Medium, Mass Production and CDMO, Cryogenic Vial (Class 2 Medical Device), and Testing services. It operates in single segment. Geographically, its operations are spread across Taiwan, Japan and Others with Taiwan generating the majority of the revenue.
83GF Score

Get the complete analysis for TPE:6794

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$78.30
Price
NT$101.84
GF Value